Zhang H, Zhang Q, Chen X, Wang M, Li L, Yu C. Establishment of a transgene-free iPS cell line (SDCHi008-A) from a young patient bearing a KCNQ2 mutation and suffering from Epilepsy. Stem Cell Res. 2024;80:103507 pubmed publisher

Zhang H, Zhang T, Wang Y, Shi J, Meng Y, Zhang Q, et al. Establishment of a transgene-free iPS cell line (SDCHi007-A) from a young patient bearing a ATP1A2 mutation and suffering from Epilepsy. Stem Cell Res. 2024;79:103490 pubmed publisher

Co H, Wu C, Lee Y, Chen S. Emergence of large-scale cell death through ferroptotic trigger waves. Nature. 2024;631:654-662 pubmed publisher

Bratti M, Stubbs E, Kolodych S, Souchet H, Kelly L, Merlin J, et al. INA03: A Potent Transferrin-Competitive Antibody-Drug Conjugate against CD71 for Safer Acute Leukemia Treatment. Mol Cancer Ther. 2024;23:1159-1175 pubmed publisher

Li Z, Liu C, Xin H, Lv Y, Gao M, Ma J, et al. Establishment of a non-integrated iPSC line (SDQLCHi043-A) from a male infant with propionic acidemia carrying compound heterozygote mutations in PCCB gene. Stem Cell Res. 2024;76:103352 pubmed publisher

Yang X, Fan Y, Li Y, Zhang H, Wang B, Guan J, et al. Generation and characterization of PBMCs-derived human induced pluripotent stem cell (iPSC) line SDQLCHi050-A from a healthy donor. Stem Cell Res. 2024;74:103266 pubmed publisher

Yang X, Zhang H, Gao M, Lv Y, Song W, Duan C, et al. An induced pluripotent stem cell line (SDQLCHi062-A) from a patient carrying a mutation in the PAX2 gene. Stem Cell Res. 2023;73:103260 pubmed publisher

Gao C, Liu Y, Liu N, Li Z, Yang X, Yang Y, et al. Establishment of human induced pluripotent stem cell line (SDQLCHi060-A) from a patient with AUTS2 syndrome carrying a heterozygous mutation in AUTS2 gene. Stem Cell Res. 2023;73:103242 pubmed publisher

Wang Y, Yang X, Zhang H, Liu N, Liu Y, Gai Z, et al. Generation of a transgene-free iPS cell line (SDQLCHi053-A) from a young girl carrying a heterozygous mutation (c.427C > T) in SYNGAP1 gene. Stem Cell Res. 2023;71:103132 pubmed publisher

Fan Y, Li Y, Yang X, Zhang H, Wang B, Guan J, et al. Generation and characterization of PBMCs-derived human induced pluripotent stem cell (iPSC) line SDQLCHi051-A from an autism spectrum disorder patient with compound CHD8 gene mutations. Stem Cell Res. 2023;69:103114 pubmed publisher

Martins G, Nonaka C, Rossi E, de Lima A, Adanho C, Oliveira M, et al. Evaluation of 2D and 3D Erythroid Differentiation Protocols Using Sickle Cell Disease and Healthy Donor Induced Pluripotent Stem Cells. Cells. 2023;12: pubmed publisher

Ai D, Yang X, Li X, Liu N, Xie X, Liu Y, et al. Generation of an induced pluripotent stem cell line SDPHi002-A from a patient with lung cancer. Stem Cell Res. 2023;69:103096 pubmed publisher

Badat M, Ejaz A, Hua P, Rice S, Zhang W, Hentges L, et al. Direct correction of haemoglobin E β-thalassaemia using base editors. Nat Commun. 2023;14:2238 pubmed publisher

Xi Y, Zhang H, Wang B, Song W, Liu Y. Establishment of an induced pluripotent stem cell line SDQLCHi049-A from a healthy male neonate. Stem Cell Res. 2023;69:103097 pubmed publisher

Chowdhury O, Ghosh S, Das A, Liu H, Shang P, Stepicheva N, et al. Sustained systemic inflammation increases autophagy and induces EMT/fibrotic changes in mouse liver cells: Protection by melatonin. Cell Signal. 2023;101:110521 pubmed publisher

Wang Y, Lv Y, Yang X, Li Y, Li Z, Gao Z, et al. Generation of an induced pluripotent stem cell line (SDQLCHi044-A) from a patient with autosomal dominant mental retardation type 5 harboring heterozygous mutation in SYNGAP1 gene. Stem Cell Res. 2022;64:102922 pubmed publisher

Truch J, Downes D, Scott C, G xfc r E, Telenius J, Repapi E, et al. The chromatin remodeller ATRX facilitates diverse nuclear processes, in a stochastic manner, in both heterochromatin and euchromatin. Nat Commun. 2022;13:3485 pubmed publisher

Stevens Hernandez C, Flatt J, Kupzig S, Bruce L. Reticulocyte Maturation and Variant Red Blood Cells. Front Physiol. 2022;13:834463 pubmed publisher

Tipgomut C, Khuhapinant A, Wilson M, Poldee S, Heesom K, Metheetrairut C, et al. MTAP-related increased erythroblast proliferation as a mechanism of polycythaemia vera. Sci Rep. 2021;11:22483 pubmed publisher

Li Z, Zhang X, Li X, Yang Y, Xin H, Yang X, et al. A non-integrated iPSC line (SDQLCHi042-A) from a boy suffering from familial combined hyperlipidemia with compound heterozygous mutations of lipoprotein lipase gene. Stem Cell Res. 2021;53:102313 pubmed publisher

Yamamoto R, Yoden E, Tanaka N, Kinoshita M, Imakiire A, Hirato T, et al. Nonclinical safety evaluation of pabinafusp alfa, an anti-human transferrin receptor antibody and iduronate-2-sulfatase fusion protein, for the treatment of neuronopathic mucopolysaccharidosis type II. Mol Genet Metab Rep. 2021;27:100758 pubmed publisher

Zhang H, Liu C, Ma Y, Lin L, Lv Y, Gao M, et al. Generation of an induced pluripotent stem cell line SDQLCHi026-A from a hereditary tyrosinemia type I patient carrying compound heterozygote mutations in FAH gene. Stem Cell Res. 2021;53:102331 pubmed publisher

Barnier J, Euphrasie D, Join Lambert O, Audry M, Schönherr Hellec S, Schmitt T, et al. Type IV pilus retraction enables sustained bacteremia and plays a key role in the outcome of meningococcal sepsis in a humanized mouse model. PLoS Pathog. 2021;17:e1009299 pubmed publisher

Yang X, Liu N, Mu H, Lv Y, Zhang H, Li Y, et al. Reprogramming of human peripheral blood mononuclear cell (PBMC) from a patient suffering from hearing loss into iPSC line (SDQLCHi035-A) maintaining compound heterozygous variations in GJB2 gene. Stem Cell Res. 2021;51:102188 pubmed publisher

Yang X, Duan C, Zhang H, Li Y, Guan J, Wang D, et al. Establishment of a non-integrate iPS cell line (SDQLCHi023-A) from a patient with Xq25 microduplication syndrome carrying a 1.3 Mb hemizygote duplication at chrXq25. Stem Cell Res. 2021;51:102147 pubmed publisher

Wang B, Yang L, Li Y, Gao M, Zhang H, Yang X, et al. Establishment of a human induced pluripotent stem cell line (SDQLCHi037-A) from a patient with Alagille syndrome carrying heterozygous mutation in JAG1 gene. Stem Cell Res. 2021;51:102162 pubmed publisher

Zhang H, Zhang H, Ma Y, Lv Y, Gai Z, Liu Y. Generation and characterization of an induced pluripotent stem cell line SDQLCHi018-A from a congenital myasthenic syndrome patient carrying compound heterozygote mutations in RAPSN gene. Stem Cell Res. 2021;51:102160 pubmed publisher

Liu N, Yang X, Wang S, Dong R, Li Y, Lv Y, et al. PBMC-derived integration-free iPSCs line SDQLCHi039-A from a patient with X-linked agammaglobulinemia carrying a novel 9-bp in-frame deletion in BTK gene. Stem Cell Res. 2021;51:102165 pubmed publisher

Wang B, Liu C, Zhang H, Gai Z, Liu Y. An induced pluripotent stem cell line (SDQLCHi033-A) derived from a patient with maple syrup urine disease type Ib carrying a homozygous mutation in BCKDHB gene. Stem Cell Res. 2020;50:102146 pubmed publisher

Walczak J, Camargo Johnson M, MUTHUMALAIAPPAN K. Stage Specific Expression Pattern of Alpha-Hemoglobin-Stabilizing-Protein (AHSP) Portrayed in Erythroblast Chronology. Methods Protoc. 2020;3: pubmed publisher

Flatt J, Stevens Hernandez C, Cogan N, Eggleston D, Haines N, Heesom K, et al. Expression of South East Asian Ovalocytic Band 3 Disrupts Erythroblast Cytokinesis and Reticulocyte Maturation. Front Physiol. 2020;11:357 pubmed publisher

Tang X, Liu X, Chen Z, Luo L, Liu X, Deng J, et al. Using inducible lentiviral vectors to generate induced pluripotent stem cell line ZOCi001-A from peripheral blood cells of a patient with CRB1-/- retinitis pigmentosa. Stem Cell Res. 2020;45:101817 pubmed publisher

Di Matteo F, Pipicelli F, Kyrousi C, Tovecci I, Penna E, Crispino M, et al. Cystatin B is essential for proliferation and interneuron migration in individuals with EPM1 epilepsy. EMBO Mol Med. 2020;12:e11419 pubmed publisher

Zhang H, Ma Y, Lv Y, Wan Y, Zhao Q, Gai Z, et al. An integration-free iPSC line SDQLCHi025-A from a girl with multiminicore disease carrying compound heterozygote mutations in RYR1 gene. Stem Cell Res. 2020;45:101775 pubmed publisher

Liu X, Yang X, Li Y, Wang X, Ma J, Jiang W, et al. Generation of patient-specific pluripotent induced stem cell line SDUBMSI002-A from a patient with X-linked mental retardation syndrome. Stem Cell Res. 2020;43:101724 pubmed publisher

Ma Y, Zhang H, Li X, Yang X, Li Y, Guan J, et al. An integration-free iPSC line (SDQLCHi017-A) derived from a patient with nemaline myopathy-2 disease carrying compound heterozygote mutations in NEB gene. Stem Cell Res. 2020;43:101729 pubmed publisher

Guan J, Li Z, Zhang H, Yang X, Ma Y, Li Y, et al. Generation of a Human iPSC line (SDQLCHi021-A) from a patient with methylmalonic acidemia cblC type carrying compound heterozygous mutations in MMAHC gene. Stem Cell Res. 2020;43:101709 pubmed publisher

Xiaojing W, Yanyan M, Ruonan D, Xiaolin L, Haiyan Z, Jian M, et al. Generation of a human induced pluripotent stem cell line (SDUBMSi001-A) from a hereditary spastic paraplegia patient carrying kif1a c.773C>T missense mutation. Stem Cell Res. 2020;43:101727 pubmed publisher

Yang X, Yan B, Zhang H, Ma Y, Zhou Q, Li Y, et al. Generation of an induced pluripotent stem cell line (SDQLCHi009-A) from a patient with 47,XXY and ornithine transcarbamylase deficiency carrying a hemizygote mutation in OTC. Stem Cell Res. 2020;43:101704 pubmed publisher

Pandey P, Tomney A, Woon M, Uth N, Shafighi F, Ngabo I, et al. End-to-End Platform for Human Pluripotent Stem Cell Manufacturing. Int J Mol Sci. 2019;21: pubmed publisher

Zhang H, Ma Y, Li X, Yang X, Li Y, Guan J, et al. An integration-free iPSC line (SDQLCHi013-A) derived from a patient with maple syrup urine disease carrying compound heterozygote mutations in BCKDHA gene. Stem Cell Res. 2019;41:101585 pubmed publisher

Zhang H, Ma Y, Yu S, Yang X, Li Y, Guan J, et al. Establishment of a human iPSC line (SDQLCHi010-A) from a patient with optic nerve malformation carrying a heterozygous mutation in PAX6 gene. Stem Cell Res. 2019;41:101611 pubmed publisher

Ma Y, Zhang H, Zhang S, Dong R, Yang X, Li Y, et al. An integration-free iPSC line (SDQLCHi012-A) derived from a patient with inflammatory bowel disease- 28 carrying compound heterozygote mutations in IL10RA gene. Stem Cell Res. 2019;41:101577 pubmed publisher

Li Y, Zhang H, Yan B, Ma Y, Yang X, Guan J, et al. An induced pluripotent stem cell line (SDQLCHi006-A) derived from a patient with maple syrup urine disease type Ib carrying compound heterozygous mutations of p.R168C and p.T322I in BCKDHB gene. Stem Cell Res. 2019;40:101579 pubmed publisher

Ma Y, Zhang H, Yang X, Li Y, Guan J, Lv Y, et al. Establishment of a human induced pluripotent stem cell line (SDQLCHi004-A) from a patient with nemaline myopathy-4 disease carrying heterozygous mutation in TPM2 gene. Stem Cell Res. 2019;40:101559 pubmed publisher

Martin R, Ikeda K, Cromer M, Uchida N, Nishimura T, Romano R, et al. Highly Efficient and Marker-free Genome Editing of Human Pluripotent Stem Cells by CRISPR-Cas9 RNP and AAV6 Donor-Mediated Homologous Recombination. Cell Stem Cell. 2019;24:821-828.e5 pubmed publisher

Denis K, Le Bris M, Le Guennec L, Barnier J, Faure C, Gouge A, et al. Targeting Type IV pili as an antivirulence strategy against invasive meningococcal disease. Nat Microbiol. 2019;4:972-984 pubmed publisher

Poldee S, Metheetrairut C, Nugoolsuksiri S, Frayne J, Trakarnsanga K. Optimization of an erythroid culture system to reduce the cost of in vitro production of red blood cells. MethodsX. 2018;5:1626-1632 pubmed publisher

Hopkinson B, Desler C, Kalisz M, Vestentoft P, Juel Rasmussen L, Bisgaard H. Bioenergetic Changes during Differentiation of Human Embryonic Stem Cells along the Hepatic Lineage. Oxid Med Cell Longev. 2017;2017:5080128 pubmed publisher

Bergounioux J, Coureuil M, Belli E, Ly M, Cambillau M, Goudin N, et al. Experimental Evidence of Bacterial Colonization of Human Coronary Microvasculature and Myocardial Tissue during Meningococcemia. Infect Immun. 2016;84:3017-23 pubmed publisher

Huang X, Wang Y, Yan W, Smith C, Ye Z, Wang J, et al. Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation. Stem Cells. 2015;33:1470-9 pubmed publisher

Staquicini F, Ozawa M, Moya C, Driessen W, Barbu E, Nishimori H, et al. Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma. J Clin Invest. 2011;121:161-73 pubmed publisher